European Society of Clinical Microbiology and Infectious Diseases

{{Short description|Swiss-based scientific international organization}} {{Primary sources|date=March 2021}} {{Use dmy dates|date=January 2024}} {{Infobox organization | name = European Society of Clinical Microbiology and Infectious Diseases | image = ESCMID logo.svg | image_size = 80 px | image_alt = | caption = Logo of the ESCMID | logo = | logo_size = | logo_alt = | logo_caption = | abbreviation = ESCMID | merged_into = | successor = | formation = {{start date and age|1983|02|12}}; known as European Society of Clinical Microbiology (ESCM) before 1990<ref name="auto">[https://www.escmid.org/fileadmin/src/media/pictures/contentpictures/Yearbook/ESCMID_TheFirst35Years_300dpi.pdf The first 35 years] {{Webarchive|url=https://web.archive.org/web/20200323170635/https://www.escmid.org/fileadmin/src/media/pictures/contentpictures/Yearbook/ESCMID_TheFirst35Years_300dpi.pdf |date=23 March 2020 }} escmid.org</ref> | founder = | founding_location = | status = | purpose = | professional_title = | headquarters = Basel, Switzerland | location = | coordinates =  | origins = | region_served = Europe | products = | services = | methods = | fields = Medical microbiology, Infectious Diseases | membership = 11K people | num_members_year = 2024 | language = | leader_title = President | leader_name = Prof. Jon S. Friedland (since 2026) | leader_title2 = Executive Committee | leader_name2 = {{Plainlist| * Prof. Jon S. Friedland (President-elect & Secretary General) * Prof. Annelies Zinkernagel (Immediate past president & Treasurer) * Dr. Gülsen Özkaya Sahin (Scientific Affairs Officer) * Prof. Emmanuelle Cambau (Education Officer) * Prof. Anu Kantele (Professional Affairs Officer) * Dr. José Ramón Paño-Pardo (Publication & Guidelines Officer) * Prof. Fidelma Fitzpatrick (Pandemic Preparedness Officer) }} | leader_title3 = | leader_name3 = | leader_title4 = | leader_name4 = | board_of_directors = | key_people = Simone Brüderli (COO of ESCMID Office) | main_organ = | parent_organization = | subsidiaries = | secessions = | affiliations = EUCAST | budget = | budget_year = | revenue = | revenue_year = | disbursements = | expenses = | expenses_year = | endowment = | endowment_year = | num_staff = | num_staff_year = | num_volunteers = | num_volunteers_year = | num_students = | num_students_year = | website = {{URL|https://www.escmid.org}} | remarks = | former_name = }} The '''European Society of Clinical Microbiology and Infectious Diseases''' (ESCMID) is a non-profit international organization with headquarters in Basel, Switzerland. An important activity of the society is the organization of the annual scientific congress ESCMID Global (formerly known as ECCMID).<ref>{{Cite web |title=ESCMID Global: ESCMID Global 2024 |url=https://www.eccmid.org/ |access-date=2024-05-21 |website=www.eccmid.org}}</ref>

The congress began as a biannual event, with about 1,500 participants at its inaugural occurrence in 1983. It became an annual event in 2000, and it has grown since then, now attracting over 16,000 participants annually.<ref>{{Cite web |title=ESCMID Global: Scientific Programme |url=https://www.eccmid.org/scientific-programme |access-date=2024-05-22 |website=www.eccmid.org}}</ref> More than 5,000 scientific abstracts are submitted for inclusion each year by researchers from multiple countries. The most recent ESCMID Global was held in April 2026 in a hybrid format, both online and onsite, in Munich, Germany.<ref name="auto2">{{Cite web|website=escmid.org |url=https://www.escmid.org/dates_events/eccmid/|title = Escmid: Eccmid}}</ref>

==Structure== ESCMID is headquartered in Basel, Switzerland. The main governance organ is the executive committee (EC), which is elected by ESCMID members, and divided further into several subcommittees with specific functions (professional affairs, education, scientific affairs, ECCMID program, publication, international affairs, ethics advisory, guidelines). The Assembly of Members takes place at the annual ECCMID, which serves as a forum for discussion and resolution of professional matters of common interest. The EC elects a president for a two-year term. The current President is Dr. Robert Leo Skov of the Statens Serum Institut in Copenhagen, Denmark. The President-elect and Secretary General is Prof. Jon S. Friedland of St. George’s, University of London in London, United Kingdom.<ref name="auto1">{{cite web |title=Brochure 2021 |url=https://www.escmid.org/about-us/the-society/leadership-committees |website=escmid.org}}</ref> ESCMID currently counts professionals from 133 countries across the world among its members.<ref name="auto" /><ref>{{Cite web |title=Escmid: Eucic |url=https://www.escmid.org/research_projects/eucic/ |website=escmid.org}}</ref>

==Activities== ===Guidelines=== ESCMID also promotes the development and dissemination of clinical and laboratory practice guidelines according to the principles of evidence-based medicine, to harmonize European diagnostic, therapeutic, and infection control procedures. Main operational procedures for guideline development are reported in the ESCMID manual for clinical practice guidelines and other guidance documents. Examples of recently published documents focused on drug treatment and clinical management of COVID-19,<ref>{{cite journal | url=https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00634-0/fulltext | pmid=34823008 | doi=10.1016/j.cmi.2021.11.007 | title=ESCMID COVID-19 living guidelines: Drug treatment and clinical management | journal=Clinical Microbiology and Infection | date=February 2022 | volume=28 | issue=2 | pages=222–238 | last1=Bartoletti | first1=Michele | last2=Azap | first2=Ozlem | last3=Barac | first3=Aleksandra | last4=Bussini | first4=Linda | last5=Ergonul | first5=Onder | last6=Krause | first6=Robert | last7=Paño-Pardo | first7=José Ramón | last8=Power | first8=Nicholas R. | last9=Sibani | first9=Marcella | last10=Szabo | first10=Balint Gergely | last11=Tsiodras | first11=Sotirios | last12=Verweij | first12=Paul E. | last13=Zollner-Schwetz | first13=Ines | last14=Rodríguez-Baño | first14=Jesús | pmc=8606314 }}</ref> Lyme disease,<ref>{{Cite journal|pmid = 33251700|year = 2021|last1 = Lantos|first1 = P. M.|last2 = Rumbaugh|first2 = J.|last3 = Bockenstedt|first3 = L. K.|last4 = Falck-Ytter|first4 = Y. T.|last5 = Aguero-Rosenfeld|first5 = M. E.|last6 = Auwaerter|first6 = P. G.|last7 = Baldwin|first7 = K.|last8 = Bannuru|first8 = R. R.|last9 = Belani|first9 = K. K.|last10 = Bowie|first10 = W. R.|last11 = Branda|first11 = J. A.|last12 = Clifford|first12 = D. B.|last13 = Dimario Jr|first13 = F. J.|last14 = Halperin|first14 = J. J.|last15 = Krause|first15 = P. J.|last16 = Lavergne|first16 = V.|last17 = Liang|first17 = M. H.|last18 = Cody Meissner|first18 = H.|last19 = Nigrovic|first19 = L. E.|author20 = Nocton JJJ|last21 = Osani|first21 = M. C.|last22 = Pruitt|first22 = A. A.|last23 = Rips|first23 = J.|last24 = Rosenfeld|first24 = L. E.|last25 = Savoy|first25 = M. L.|last26 = Sood|first26 = S. K.|last27 = Steere|first27 = A. C.|last28 = Strle|first28 = F.|last29 = Sundel|first29 = R.|last30 = Tsao|first30 = J.|title = Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease|journal = Arthritis Care & Research|volume = 73|issue = 1|pages = 1–9|doi = 10.1002/acr.24495|s2cid = 227237140|display-authors = 1|doi-access = free}}</ref> Sepsis,<ref>{{Cite journal|url=https://journals.lww.com/ccmjournal/fulltext/2021/11000/surviving_sepsis_campaign__international.21.aspx|doi = 10.1097/CCM.0000000000005337|title = Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021|year = 2021|last1 = Evans|first1 = Laura|last2 = Rhodes|first2 = Andrew|last3 = Alhazzani|first3 = Waleed|last4 = Antonelli|first4 = Massimo|last5 = Coopersmith|first5 = Craig M.|last6 = French|first6 = Craig|last7 = Machado|first7 = Flávia R.|last8 = McIntyre|first8 = Lauralyn|last9 = Ostermann|first9 = Marlies|last10 = Prescott|first10 = Hallie C.|last11 = Schorr|first11 = Christa|last12 = Simpson|first12 = Steven|last13 = Wiersinga|first13 = W. Joost|last14 = Alshamsi|first14 = Fayez|last15 = Angus|first15 = Derek C.|last16 = Arabi|first16 = Yaseen|last17 = Azevedo|first17 = Luciano|last18 = Beale|first18 = Richard|last19 = Beilman|first19 = Gregory|last20 = Belley-Cote|first20 = Emilie|last21 = Burry|first21 = Lisa|last22 = Cecconi|first22 = Maurizio|last23 = Centofanti|first23 = John|last24 = Coz Yataco|first24 = Angel|last25 = De Waele|first25 = Jan|last26 = Dellinger|first26 = R. Phillip|last27 = Doi|first27 = Kent|last28 = Du|first28 = Bin|last29 = Estenssoro|first29 = Elisa|last30 = Ferrer|first30 = Ricard|journal = Critical Care Medicine|volume = 49|issue = 11|pages = e1063–e1143|pmid = 34605781|s2cid = 238257608|display-authors = 1|doi-access = free}}</ref> Clostridioides difficile infection.<ref>{{Cite journal|pmid = 34678515|year = 2021|last1 = Van Prehn|first1 = J.|last2 = Reigadas|first2 = E.|last3 = Vogelzang|first3 = E. H.|last4 = Bouza|first4 = E.|last5 = Hristea|first5 = A.|last6 = Guery|first6 = B.|last7 = Krutova|first7 = M.|last8 = Norén|first8 = T.|last9 = Allerberger|first9 = F.|last10 = Coia|first10 = J. E.|last11 = Goorhuis|first11 = A.|last12 = Van Rossen|first12 = T. M.|last13 = Ooijevaar|first13 = R. E.|last14 = Burns|first14 = K.|last15 = Scharvik Olesen|first15 = B. R.|last16 = Tschudin-Sutter|first16 = S.|last17 = Wilcox|first17 = M. H.|author18 = Vehreschild MJGT|last19 = Fitzpatrick|first19 = F.|last20 = Kuijper|first20 = E. J.|author21 = Guideline Committee of the European Study Group on Clostridioides difficile|title = European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults|journal = Clinical Microbiology and Infection |volume = 27| issue=Suppl 2 |pages = S1–S21|doi = 10.1016/j.cmi.2021.09.038|s2cid = 239473944|doi-access = free}}</ref>

===ESCMID Study Groups=== ESCMID study groups are special interest groups consisting of society members who are involved in the study of specific areas of clinical microbiology and infectious diseases. The study groups are involved in proposing scientific symposia, educational workshops, and meet-the-expert sessions for ECCMID, proposing educational courses/workshops, and publishing scientific articles in ESCMID's name.<ref>{{cite journal |last1=Dyar |first1=O. J. |last2=Beović |first2=B. |last3=Pulcini |first3=C. |last4=Tacconelli |first4=E. |last5=Hulscher |first5=M. |last6=Cookson |first6=B. |last7=Ashiru-Oredope |first7=D. |last8=Barcs |first8=I. |last9=Blix |first9=H. S. |last10=Buyle |first10=F. |last11=Chowers |first11=M. |last12=Čižman |first12=M. |last13=Cookson |first13=B. |last14=Del Pozo |first14=J. L. |last15=Deptula |first15=A. |last16=Dumpis |first16=U. |last17=Florea |first17=D. |last18=van de Garde |first18=E. |last19=Geffen |first19=Y. |last20=Giske |first20=C. G. |last21=Grau |first21=S. |last22=Hajdú |first22=E. |last23=Hell |first23=M. |last24=Hondo |first24=Ł. |last25=Hussein |first25=K. |last26=Huttner |first26=B. |last27=Kern |first27=W. |last28=Kernéis |first28=S. |last29=Knepper |first29=V. |last30=Kofteridis |first30=D. |last31=Kostyanev |first31=T. |last32=Kuijper |first32=E. |last33=Lebanova |first33=H. |last34=Lewis |first34=R. |last35=Cordina |first35=C. M. |last36=Matulionyte |first36=R. |last37=Maurer |first37=F. |last38=Messiaen |first38=P. |last39=Miciuleviciene |first39=J. |last40=Mrhar |first40=A. |last41=Nabuurs-Franssen |first41=M. |last42=Naesens |first42=R. |last43=Oxacelay |first43=C. |last44=Pagani |first44=L. |last45=Paño-Pardo |first45=J. R. |last46=Paul |first46=M. |last47=Petrikkos |first47=G. |last48=Pluess-Suard |first48=C. |last49=Popescu |first49=G. A. |last50=Porsche |first50=U. |last51=Prins |first51=J. |last52=Pulcini |first52=C. |last53=Rello |first53=J. |last54=Rodríguez-Baño |first54=J. |last55=Rossolini |first55=G. M. |last56=Salzberger |first56=B. |last57=Seme |first57=K. |last58=Simonsen |first58=G. S. |last59=Sînziana |first59=M. |last60=Skovgaard |first60=S. |last61=Smith |first61=I. |last62=Sönsken |first62=U. |last63=Soriano |first63=A. |last64=Sviestiņa |first64=I. |last65=Szilagyi |first65=E. |last66=Tängdén |first66=T. |last67=Tattevin |first67=P. |last68=Tsioutis |first68=C. |last69=Vilde |first69=A. |last70=Wanke-Rytt |first70=M. |last71=Wechsler-Fördös |first71=A. |last72=Zarb |first72=P. |title=ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus |journal=Clinical Microbiology and Infection |date=1 January 2019 |volume=25 |issue=1 |pages=13–19 |doi=10.1016/j.cmi.2018.09.022 |pmid=30414817 |s2cid=53284803 |doi-access=free |hdl=2066/202235 |hdl-access=free }}</ref> During the COVID-19 pandemic, several study groups began producing virtual content, such as web-symposia series or online conferences.

===ESCMID Global (formerly known as ECCMID)=== ESCMID Global is recognized as the largest international forum for presentations and discussions of research in the fields of clinical microbiology and infection for academic, clinical, and industry experts. The first European Congress of Clinical Microbiology (ECCM) was organized in 1983 in Bologna, Italy. After the inclusion of infectious diseases in the late 1980s, the first ECCMID was held in 1991 in Oslo, Norway. Initially a biannual congress, ESCMID Global has been an annual event since 2000. Since its initiation with around 1,500 participants, the congress has grown and now attracts around 14,000 participants every year.<ref name="auto2"/><ref name="auto"/> The number of submitted abstracts has risen to over 5,000, of which roughly 70% are accepted for oral or poster presentation. A large pharmaceutical exhibition site alongside a broad-based program in clinical microbiology and infectious diseases. In 2024 the name of the congress was changed from ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) to ESCMID Global.

===Clinical Microbiology and Infection=== Clinical Microbiology and Infection (CMI) is the official peer-reviewed ESCMID publication, which publishes monthly issues and additional supplements devoted to special themes. The scope of the journal comprises basic and applied research relevant to therapy and diagnostics in the fields of microbiology, infectious diseases, virology, parasitology, immunology, and epidemiology as related to these fields.<ref>{{cite web |url=https://www.clinicalmicrobiologyandinfection.com/ |title=Home |website=clinicalmicrobiologyandinfection.com}}</ref>

===Professional Affairs=== ESCMID supports the career development of members by creating a platform for them to connect with experienced professionals in their field.

One such activity is the Observership program, which allows infectious diseases specialists and clinical microbiologists to visit renowned centers outside their country.

The Mentorship program is accessible to full ESCMID and young scientist members, who can receive guidance for research and career development from a senior ESCMID member.

The ESCMID Parity Commission was founded to review and improve representation of minorities as well as gender and geographical balance in the society's fields of expertise.<ref name="auto1" />

The Trainee Association of ESCMID (TAE) aims at widening career opportunities for young scientists at the beginning of their careers. Among other professional affairs activities are the cooperation with other organizations in clinical microbiology and infectious diseases; Collaboration with relevant sections of the European Union of Medical Specialists (UEMS); Professional policy issues in the fields of clinical microbiology and infectious diseases; Matters relating to professional training, mobility and recruitment; Equal opportunities; Trainees' issues.<ref name="auto1" />

===Awards and Grants=== ESCMID supports young clinicians and researchers as well as established scholars with awards and grants to acknowledge past achievements and provide an incentive for future accomplishments. ESCMID supports its members' research projects and training with around seven hundred thousand euros every year.<ref>{{Cite web |title=ESCMID Brochure 2021 |url=https://markterfolg.de/ESCMID/PDFViewerBrochure/#page=1 |website=markterfolg.de}}</ref>

==References== {{Reflist}}

==External links== * [https://www.escmid.org/ ESCMID] * [https://eucast.org/ EUCAST]

Category:1983 establishments in Switzerland Category:Biology in Europe Category:International medical associations of Europe Category:International medical and health organizations Category:Medical associations based in Switzerland Category:Microbiology societies Category:Organisations based in Basel Category:Scientific organizations established in 1983 Category:Virology organizations Category:Learned societies of Switzerland Category:Organizations established in 1983

European Society of Clinical Microbiology and Infectious Diseases

Connections

Linked from

Links to (46 total)